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Abstract
Disability Adjusted Life Years (DALYs) combine the number of people affected by disease or
mortality in a population and the duration and severity of their condition into one number. The
environmental burden of disease is the number of DALYs that can be attributed to environmental
factors. Environmental burden of disease estimates enable policy makers to evaluate, compare and
prioritize dissimilar environmental health problems or interventions. These estimates often have
various uncertainties and assumptions which are not always made explicit. Besides statistical
uncertainty in input data and parameters – which is commonly addressed – a variety of other types
of uncertainties may substantially influence the results of the assessment. We have reviewed how
different types of uncertainties affect environmental burden of disease assessments, and we give
suggestions as to how researchers could address these uncertainties. We propose the use of an
uncertainty typology to identify and characterize uncertainties. Finally, we argue that uncertainties
need to be identified, assessed, reported and interpreted in order for assessment results to
adequately support decision making.
Background
In environmental health research, focus has shifted from
relatively simple to more complex issues. Empirical single
agent – single effect studies have been supplemented by
research on risks of complex environmental exposures in
varying economic, cultural and political settings. Environ-
mental health impact assessment has become a valuable
tool for decision support. These types of assessments
increasingly use so-called environmental burden of dis-
ease (eBoD) measures to express health impacts. The
eBoD can be viewed as the gap – caused by environmental
factors – between current health status and an alternative
situation in which environmental exposures are reduced
or eliminated. Burden of disease estimates enable com-
parison of divergent environmental health problems. This
in turn enables policy makers to set priorities. However,
scientists often have to make many assumptions when
assessing the eBoD. Knowledge and data are often incom-
plete, and diverging perceptions exist about what the most
important aspects of a problem are. Assessments are often
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highly interdisciplinary, complex and multifaceted, and
the uncertainty about results can be significant [1]. This
may affect decision making based on these assessments.
A 2005 comparison of 17 eBoD studies published
between 1996 and 2005 (internal RIVM/MNP publication
by Knol et al.) showed that there are significant differ-
ences between eBoD estimates that concern – at first sight
– similar issues. Smith et al. [2], for example, estimate the
fraction of the total global disease burden attributable to
the environment to be 25–33%, whereas Melse and de
Hollander [2,3] estimate this to be 7.5 to 11% (for OECD
countries only: 2–5%). Such differences can sometimes
not be fully explained by reading the assessment reports.
Methods, assumptions and input data are often insuffi-
ciently explained, which hampers interpretation and com-
parability of results. Fox-Rushby and Hanson [4] show
that 9 out of 16 papers on burden of disease published
between 1993 and 2000 did not declare the underlying
assumptions.
Even though it is never possible to reduce uncertainty to
zero in these complex assessments, there is significant
room for improvement in dealing with uncertainty [1].
Various eBoD studies have addressed the need for uncer-
tainty and sensitivity analyses (for example [2,4-10]), but,
as yet, these analyses are based primarily on statistical
uncertainty of some parameters and input data. Other
sources of uncertainty are often touched upon in the dis-
cussion sections of publications, but usually not in a sys-
tematic manner. However, many environmental health
issues are not straightforward and uncertainties cannot be
captured in simple confidence intervals [11,12]. Only if
both scientists and policy makers realize the potential
extent of uncertainties and the way they may affect the
assessment results, can these assessments lead to truly
informed policy making. In order to achieve this, a typol-
ogy of different dimensions of uncertainty can help to
structure, assess and potentially reduce uncertainties, and
moreover to improve the dialogue about uncertainties
between scientists and policy makers.
The present study explores the different types of uncer-
tainty that may play a role in eBoD studies expressed in
Disability Adjusted Life Years, structured using a typology.
The impact that uncertainties can have on assessment
results – and thereby on decision making – will be illus-
trated using examples from the existing eBoD literature.
Some suggestions are given as to how to address and com-
municate uncertainties to policy makers. This paper aims
to create awareness among environmental health impact
assessors about the potential impact and importance of
uncertainties, and to provide a practical approach and
structure to deal with uncertainties in eBoD assessments.
Disability Adjusted Life Years
An increasingly popular metric to express the environ-
mental burden of disease is the DALY (Disability Adjusted
Life Years). DALYs indicate the potential number of
healthy life years lost in a population, i.e. burden of dis-
ease. Not only life years lost due to premature mortality,
but also years spent with reduced quality of life due to dis-
eases are included. For diseases, severity weights (also
referred to as disability weights) are used to quantify the
reduced quality of life. They are developed by expert pan-
els and range from 0 for complete health to 1 for death.
Diseases with a severity weight ranging from 0.05 to 0.1
include for example low back pain, uncomplicated diabe-
tes, or mild angina. Examples of more severe diseases with
weights ranging from 0.65 to 0.8 include cancer, severe
depression, and brain injury. These specific weights have
been derived by Stouthardt et al. [13] and it should be rec-
ognized that other authorities might assign different
weights to these effects.
Additionally, DALY calculations can include age weights
and discounting factors. Age weighting involves valuing
life years lost at a certain age more than life years lost at
other ages. Discount factors are used to value present years
of life saved more than future years. The usual annual dis-
count rate is 3%, implying that a year of healthy life
gained in 10 years time is valued at 26 percent less than
one gained now. The use of age weights and discount fac-
tors has been discussed – and heavily debated – elsewhere
(for example [14,15]).
Burden of disease calculations using DALYs were first pub-
lished in the World Development Report [16]. Subse-
quently, Murray and Lopez [17] used DALYs in their
extensive Global Burden of Disease project in order to
introduce morbidity into the predominantly mortality-
based health discussions. Since then, the World Health
Organization (WHO) has endorsed the DALY approach,
and it has been used in various studies on global, national
and regional levels [3,18-26]. Burden of disease calcula-
tions are now increasingly being asked for in order to
develop, evaluate and prioritize health-related policy
measures. As well as DALYs, various other summary meas-
ures exist to express population health or disease states,
such as QALYs (Quality Adjusted Life Years), HALYs
(Health Adjusted Life Years), DALEs (Disability Adjusted
Life Expectancy), HALEs (Health Adjusted Life Expect-
ancy), and various monetary valuation measures. Even
though this paper focuses on DALYs, most of the uncer-
tainties identified play a similar role for these alternative
indicators.
Typology of uncertainty
Uncertainties in assessments about a complex world can
take many forms. A typology of uncertainty can help toEnvironmental Health 2009, 8:21 http://www.ehjournal.net/content/8/1/21
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structure the different types of uncertainties. This can in
turn help to identify useful methods and techniques to
deal with the uncertainties, ranging from stakeholder dis-
cussion to sensitivity analysis.
We have adapted existing uncertainty typologies [27-33]
to fit our purpose of identifying, further characterizing
and dealing with the uncertainties that arise in eBoD
assessments. Our typology (Table 1) distinguishes
between location, nature, range, recognized ignorance,
methodological unreliability and value diversity among
analysts, as six characteristics of uncertainty. These charac-
teristics apply simultaneously to a piece of uncertain
information. This typology differs from the one presented
by Petersen [30] in the way in which the location of uncer-
tainty and ontic uncertainty are specified. These changes
have been made in order to make the typology more
applicable to burden of disease assessments. How the
typology presented by Petersen differs from previous
typologies such as [27,28,32] is described in [30]. It is not
claimed that our typology is the best typology (cf [30]);
for other purposes, other typologies might be more useful.
First, the location of uncertainty indicates where the
uncertainty manifests itself among the main elements of
the assessment. Distinction is made here between the con-
text, model structure, parameters and input data. These
locations will be further described below.
Second, the nature of uncertainty expresses whether
uncertainty is primarily a consequence of the incomplete-
ness and fallibility of knowledge, epistemic uncertainty,
or primarily due to intrinsic properties of the system
under study, ontic uncertainty – ontic meaning pertaining
to the object. In other contexts and disciplines, ontic
uncertainty is often referred to as variability. The present
study distinguishes between two types of ontic uncer-
tainty: process variability and normative uncertainty.
Process uncertainty relates to variability in natural or
social processes, such as the inherent variability of the
weather. Normative uncertainty relates to the existence of
a fundamental plurality of social, ethical or normative
considerations. An example of the latter is that individuals
have fundamentally different views on wellbeing and the
severity of illnesses.
Table 1: Typology of uncertainty
Uncertainty characterizations Categories
Location: the location at which the uncertainty 
manifests itself in the   assessment
Model structure: Structure and form of the relationships between the variables that 
describe the system
Parameters: Constants in functions that define the relationships between variables 
(such as relative risks or severity weights)
Input data: Input data sets (such as concentrations, demographic data, and incidence data)
Nature: the underlying cause of the uncertainty Epistemic: resulting from incomplete knowledge
Ontic Process variability: resulting from natural and social 
variability in the system
Normative uncertainty: resulting from a plurality of socio-
ethico-normative considerations within a society
Range: expression of the uncertainty Statistical (range + chance): specified probabilities and specified outcomes
Scenario (range + "what if"): specified outcomes, but unspecified probabilities
Recognized ignorance: unknown outcomes, unknown probabilities – uncertainties are present, but no useful estimate can be given
Methodological unreliability: Methodological quality of all different elements of the assessment; a qualitative judgment of the assessment 
process which can based on e.g. its theoretical foundation, empirical basis, reproducibility and acceptance within the peer community
Value diversity among analysts: Potential value-ladenness of assumptions which inevitably involve – to some degree – arbitrary judgments by 
the analysts.Environmental Health 2009, 8:21 http://www.ehjournal.net/content/8/1/21
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Third, the range of uncertainty relates to the way uncer-
tainty can be expressed, either as a statistical uncertainty
or as a scenario uncertainty. A statistical uncertainty range
is appropriate when uncertainties can be adequately
expressed in statistical terms, for example, as a central esti-
mate and an interval around it. However, deeper forms of
uncertainty are frequently at play. These can often not be
adequately described in terms of chances or probabilities,
but can only be specified in terms of a range of possible
events (scenarios). In absence of information on the rela-
tive likelihood of each scenario, they are usually treated as
being equally plausible. Scenario uncertainties are often
construed in terms of what-if statements.
Fourth, recognized ignorance concerns those aspects of
uncertainty for which we cannot establish any useful esti-
mate, for example due to processes that have been identi-
fied but that are yet poorly understood. Unrecognized
ignorance is excluded from the typology, because it con-
cerns pure ignorance about which we cannot say anything
knowledgeable: we do not know what we do not know.
However, experts may acknowledge that they are ignorant
about particular sources of uncertainty and that this limits
the reliability of the conclusions of their studies.
Fifth, the methodological unreliability of an element of
an assessment reflects weaknesses in methodological
quality. It is often not possible to quantitatively establish
the accuracy of a model. In those cases, one may instead
use qualitative judgments to express in what ways scien-
tific knowledge is limited. Scientific peers may judge the
methodological rigor of the procedures followed. This
methodological rigor can, for instance, be determined by
looking at the theoretical and empirical basis, the repro-
ducibility of the assessment and its acceptance in the peer
community.
Sixth, there can be value diversity among analysts in scien-
tific practice. Value here refers to personal values and nor-
mative judgments, instead of to numerical values. Value
diversity is often reflected in the existence of alternative
assumptions in the assessment. Also, assumptions made
by one expert can be contested by another expert. Asses-
sors often have considerable freedom in making choices
about the design of their assessment and the interpreta-
tion of data. These choices may be influenced by different
underlying epistemic, socio-cultural and practical values
held by the assessors. An example of a socio-cultural value
is to base the assessment on worst-case assumptions,
reflecting a risk-avoiding attitude. Experts with a risk-seek-
ing attitude may find worst-case scenarios less relevant
and might prefer best-case assumptions to inform a deci-
sion [34].
The different categories of the location of uncertainty are
used to structure this paper. The other characteristics are
discussed in each of the sections. The various types of
uncertainty will be illustrated using examples from the
eBoD literature. In Table 2, some of these illustrations
have been characterized according to the uncertainty
typology. These examples are referred to with (Table 2,
section #) in the remainder of this manuscript, in which
'section #' refers to the corresponding number in Table 2.
We will also point towards methods that can be used to
deal with different types of uncertainties.
Contextual uncertainty
Contextual uncertainty stems from choices made about
system boundaries and definitions used in an assessment.
In eBoD studies, the definition of the environmental fac-
tor(s) considered, the associated health outcomes, the
links between these, and the scenarios used in the study
(including the study area, affected population, and time
frame) have to be agreed upon.
Examples of contextual uncertainty in environmental burden of 
disease assessments
Defining environment
Defining 'environment' is not always straightforward.
Whereas assessments on single risk factors can generally
define exposure relatively easy, broader multiple factor
analyses (about for example transport, agriculture or the
total environment) need to define these boundaries more
carefully.
'Environment' has been defined to exclude genetics, diet
and smoking behavior, but include for instance effects of
the natural environment such as dust exposure and natu-
ral disasters [2]; include physical, chemical and biological
human-made or influenced exposures, but exclude occu-
pational health and safety, the majority of traffic, war, and
life-style factors [3]; include all the physical, chemical and
biological factors external to the human host and all
related behaviors, but exclude those natural environments
that cannot reasonably be modified [5,24,35], etc. These
definitions can have a significant influence on the out-
come of an assessment. In technical terms, this uncer-
tainty can be addressed by thoroughly defining the terms
and scope of an assessment. However, this does not
change the fact that different scopes and definitions are
theoretically possible. Therefore, this contextual uncer-
tainty (Table 2, section 1), has an epistemic component,
because we can not yet gauge the complete extent of the
environment; and a normative component, because dif-
ferent researchers hold different normative views on what
the environment consists of.Environmental Health 2009, 8:21 http://www.ehjournal.net/content/8/1/21
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Table 2: Illustrations of characterizations of uncertainties in environmental burden of disease assessments
Source of uncertainty Nature
Epistemic/Ontic 
(Process Variability/
Normative 
Uncertainty)
Range
Statistical/Scenario
Recognized ignorance Methodological 
unreliability
Value diversity among 
analysts
CONTEXTUAL UNCERTAINTY
1 Multiple ways of defining 
the 'total environment'
E/Nor Sc - + ++
2 Only including diseases 
that cause at least 1% of 
the global burden of 
disease
Nor Sc -- -- +
MODEL STRUCTURE UNCERTAINTY
3 Specific form of the 
exposure-response 
relationship is unknown
ES c +++
4 Evidence for causality 
(environmental factor 
leading to health effect) 
is weak and 
contradicting
ES c + + + ++
5 Incomplete 
understanding of the 
joint effect of smoking 
and radon in relation to 
lung cancer
ES c +++
6 Accounting for 
susceptible groups if the 
available relative risk is 
not representative for 
this group
Pro/E St + + +
PARAMETER UNCERTAINTY
7 Determining a relative 
risk (RR) for long-term 
exposure to PM10
ES t + + -
8 Applying an American 
RR for PM10 to the 
Netherlands
ES c + + ++
9 Use of severity weights Nor/E Sc + + ++
INPUT DATA UNCERTAINTY
10 Extrapolating non-
assessment-specific 
exposure measurements
ES c + + ++
11 Measuring population 
exposure
ES t + + -Environmental Health 2009, 8:21 http://www.ehjournal.net/content/8/1/21
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Defining health
Many assessments define health quite clinically, including
only adverse health effects that have a medical diagnosis.
However, a broader definition – such as used by WHO [6]
stating that health is a state of complete physical, mental
and social well-being and not merely the absence of dis-
ease or infirmity – also includes less severe health effects.
For instance, the burden of disease related to noise varies
significantly depending on whether noise annoyance and
sleep disturbance are considered health effects.
A pragmatic and normative approach to define which dis-
eases to include in an assessment has been employed by
Smith et al. [2]. They included only disease categories that
cause at least 1% of the global burden of disease (Table 2,
section 2). Other cut-off percentages could also have been
adopted, making this source of uncertainty a form of sce-
nario uncertainty with a normative nature and a degree of
value diversity among analysts. Since it is known which
diseases are excluded and why, recognized ignorance and
methodological unreliability do not play a substantial
role.
Dealing with contextual uncertainty
Results of an assessment can be very sensitive to the defi-
nitions and system boundaries chosen. Most of these def-
initions cannot be harmonized across assessments,
because they are dependent upon the purpose of a specific
assessment [36]. There is not one single way to deal with
contextual uncertainties, but a few general guidelines can
be given. In summary, the chosen definitions and bound-
aries need to be discussed, reported and consistently used
[2,37]. This process may often need to involve relevant
stakeholders. Even though stakeholder discussions may
not reduce the uncertainties, they at least help to reveal
them [1]. If more than one sensible definition can be
made about an element in the assessment, thus leaving
room for value diversity, multiple analyses can be run
using different sets of definitions. This is especially useful
when there is controversy about which definitions are
most appropriate, or when the differences between defini-
tions are considerable. Sensitivity and decision analyses
can help to identify which sources of uncertainty mostly
affect the final results [8-10].
Model structure uncertainty
Model structure uncertainty relates to uncertainty about
the causal structure of the modeled system: uncertainty
within the boundaries chosen. Various interpretations
might prevail about the dominant variables and their
causal relationships. Because of the many difficulties in
studying the large scale low exposure environmental
health risks that are so typical of the modern Western
world, different views about the model structure often
exist.
Examples of model structure uncertainty in environmental burden of 
disease assessments
Even when the assessment context is agreed upon, that
does not automatically mean that all potentially relevant
variables are included in the assessment. For example, cli-
mate change may affect health in ways that are as yet unex-
pected and which can therefore not be assessed [38].
Model structure uncertainty can also relate to the applica-
bility and form of exposure-response relationships (for
instance, threshold versus no threshold, or linear versus
nonlinear) (Table 2, section 3) [39,40]. Additionally, evi-
dence for causality may not always be available or in
agreement (Table 2, section 4). An example is the incon-
clusiveness of the evidence for an association between
noise exposure and cardiovascular impacts. Some review-
ers find the evidence for this relationship sufficient,
whereas others state that it is limited [41]. Similarly, a
WHO eBoD study [42] based their estimate of the asthma-
related burden of disease for children on a relative risk
that Smith [43] considered not sufficiently robust. A com-
parable debate runs for the long-term health impacts of
air pollution, which are as yet rather uncertain. Since dif-
ferent decisions can be made about whether sufficient evi-
dence for causality exists [44,45], such uncertainty is
characterized as scenario uncertainty. The recognized
ignorance about the existence of causality, which is partly
due to methodological unreliability, could be reduced by
further research, which indicates its epistemic nature.
Other examples of model structure uncertainty relate to
partly unknown patho-physiological mechanisms, the use
of proxies, potential latency times, vulnerable groups, co-
morbidity and multi-causality. Multiple risk factors can
simultaneously affect multiple health outcomes. Environ-
mental stressors can cause health effects through interme-
diate factors and feedback systems. There may also be
other correlated risk factors with common social and
behavioral determinants [7,46-48]. When assessing such
interacting risk factors, it is necessary to know whether
their effects are additive (separate effects added), synergis-
tic (separate effects multiplied), or antagonistic (separate
effects reduced) [49]. Incomplete understanding of the
joint effect of smoking and radon with regard to lung can-
cer remains a key uncertainty in assessing the risk of
indoor radon [50] (Table 2, section 5). Similarly, different
methods exist to account for specific susceptible popula-
tion sub-groups when no representative exposure-
response functions exist (Table 2, section 6).
Dealing with model structure uncertainty
Model structure uncertainty is often predominantly epis-
temic – relating to incomplete or contradictory knowledge
– and more research can increase understanding and pos-
sibly reduce uncertainty.Environmental Health 2009, 8:21 http://www.ehjournal.net/content/8/1/21
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Refsgaard et al. [51] reviewed strategies for assessing
model structure uncertainty and present a framework for
assessing the uncertainties of predictive models. It
involves the use of multiple conceptual models, assess-
ment of their pedigree, and reflection on the extent to
which the sampled models adequately represent the space
of plausible models. Additionally, sensitivity and decision
analyses can provide information about the relative
importance of variation between different alternative
assumptions [8-10]. Widely used are also Bayesian belief
networks, which can be used to assess multiple model
structures [52,53].
However, resources often limit the possibility of running
extensive alternative calculations, and pragmatic choices
need to be made. Therefore it is most important to docu-
ment the assumed conceptual and technical model struc-
ture in a transparent way, to explore and document which
limitations or other viewpoints exist, and to reflect on
what this means for the robustness of the results. A graph-
ical representation of the model showing which variables
and linkages are included and excluded in the assessment
increases the understanding of the model structure [54].
Standardization of the way such causal diagrams are pre-
sented – all using the same convention for what certain
shapes of boxes and types of arrows precisely mean – is to
be recommended. Finally, if very large disagreement or
ambiguity about the model structure exists, one might
also consider not to carry out an eBoD study in the first
place.
Parameter uncertainty
Parameters are used to describe a relationship between
variables. They can be descriptive (such as relative risks,
duration estimates, or attributable fractions) or normative
(such as maximum life expectancy, severity weights, pol-
icy norms, age weights and discount factors).
Examples of parameter uncertainty in environmental burden of 
disease assessments
Relative risks and attributable fractions
The most common descriptive parameter used in eBoD
calculations is the relative risk (RR), which indicates the
ratio of the risk of a disease or death among those exposed
to the specified factor to those not exposed. The RR is usu-
ally derived from an epidemiological study or a meta-
analysis of such studies, and subsequently applied to the
specific study context. The epidemiological studies from
which the RR stems can in themselves form a source of
uncertainty (Table 2, section 7). The methods used to
derive RRs are fairly common, which limits value diver-
sity, at least among epidemiologists. However, uncer-
tainty can relate to differences in study design or
measurement errors, giving rise to potential methodolog-
ical unreliability [1]. For some environmental risks, espe-
cially new and emerging risks such as electromagnetic
fields or genetically modified foods, RR estimates are
available only to a limited degree or not at all. Depending
on the assessment context, it can be debated whether spe-
cific RRs can be extrapolated to other regions, time peri-
ods, substance mixtures, or population sub-groups
[7,39,55]. An example is the use of RRs for the long-term
effects of PM10, which are currently mainly available from
studies in the United States. The validity of the use of such
risk measures in burden of disease studies in other coun-
tries is disputable, since air pollution mixtures (for which
PM10 is an indicator) and average population susceptibil-
ity may vary between countries [11,56] (Table 2, section
8). Similarly, in assessing the health impacts of climate
change, problems have been encountered when long-term
effects have had to be extrapolated from short-term asso-
ciations [38].
Severity weights, age weights and discounting
Normative parameters such as severity weights for dis-
eases or age weights and discounting factors for future
health gains are generally based on the judgments of cli-
nicians and economists respectively. They are therefore
subjective interpretations of a number for which no 'true
value' exists (Table 2, section 9) [57]. Different values will
prevail depending on who is being asked, their age, gen-
der, occupation, socio-economic status, cultural back-
ground and education level, amongst other things. This
raises the question of the transferability of these weights
to other situations. Estimates of severity weights also
depend on the way health effects are presented to the peo-
ple who are asked to make the valuation, the range of
health effects to be valued in the same session, and the
valuation methods [58]. As an extreme example, the sever-
ity weight for severe noise-related sleep disturbance has
been estimated at 0.01 (as used in [20,59]) up to as high
as 0.12 [59]. Alternative but still realistic assumptions for
all normative parameters mentioned above (severity
weights, age weights and discounting) can lead to major
differences in DALYs, by up to a factor of four [57]. This
large variation should be a reminder of the need for cau-
tion in the use of such indicators for policy purposes. If
the choice of policy is sensitive to the precise value of the
indicator, then an indicator with a large concealed uncer-
tainty may be worse than none at all.
Dealing with parameter uncertainty
Parameter uncertainty (together with input data uncer-
tainty, discussed next) is commonly quantitatively
assessed in eBoD studies, through the use of statistical
analyses. Confidence intervals (CI) of parameters such as
the RR are used to calculate overall CIs for DALYs. This
approach is only suitable for statistical uncertainty. How-
ever, scenario uncertainty (Table 2, sections 8 and 10) on
issues for which various interpretations exist (i.e. valueEnvironmental Health 2009, 8:21 http://www.ehjournal.net/content/8/1/21
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diversity among analysts) is more difficult to represent in
CIs. For these uncertainties, similar approaches as
described for contextual and model structure uncertainty
can be useful: sensitivity and decision analyses in combi-
nation with transparent reporting.
Input data uncertainty
Uncertainty in input data may relate to a range of factors,
including a lack of data, inaccurate measurements, or
extrapolated data. Exposure data and disease data (inci-
dence, prevalence or mortality data) are the most com-
mon input data sets needed for eBoD calculations.
Examples of input data uncertainty in environmental burden of 
disease assessments
The greatest source of uncertainty pertaining to input data
in eBoD assessments generally relates to a lack of assess-
ment-specific measurements. For exposure data, one fre-
quently has to rely on proxies for exposure, such as
modeled environmental concentrations. Furthermore, for
many risk factors, data on exposure or concentration dis-
tributions are available for only a limited number of years,
regions, countries or demographic groups [5]. If no fur-
ther monitoring can take place, assessors might need to
extrapolate non-assessment specific data (Table 2, section
10). In climate change research, for example, impacts
often relate to future exposures which cannot be meas-
ured and hence need to be modeled [38]. In a WHO study
on solid fuel use across 181 countries [5,60], a combina-
tion of survey data and modeled data were used. Whether
the modeled data can be meaningfully used may be
judged differently by various scientists, leading to poten-
tial value diversity among analysts. Overall, Prüss-Üstün
et al. [5] concluded that only for three environmental risk
factors – water sanitation and hygiene, solid fuel use, and
outdoor air pollution – were the necessary methodology
and enough exposure data available to make sensible glo-
bal estimates at country level.
Even when exposure can be measured, different measur-
ing methods may lead to different results (Table 2, section
11). An example is the measurement of noise exposure
levels, which can differ by up to 10 dB(A) depending on
the methodologies used [61]. In studies related to UV
radiation and skin cancer, sun exposure of many years
before is often estimated using recalled sunburns or time
spent in the sun. Such exposure estimates based on self-
reporting can differ significantly from measurement data
of ambient UV radiation levels [40].
Similar issues play a role for background morbidity and
mortality data, which are needed to calculate the esti-
mated number of attributable cases. Such data should ide-
ally stem from empirical research or adequate monitoring
in the target population [62]. However, these data are
often only available at highly aggregated levels. More spe-
cific data, for example on a local scale, suffer from the
small-number problem, in that estimates for rare out-
comes may be highly unstable. Research shows that indic-
ative uncertainty ranges for regional prevalence rates of 16
important diseases may range from +/- 10 percent to +/-
90 percent [39]. The common solution – modeling miss-
ing data, or extrapolating data of one country to another
country – yields epistemic uncertainty.
Dealing with input data uncertainty
For morbidity data, models can be employed to calculate
missing data and check for consistency in existing data-
sets. However, past trends in incidence and data inaccura-
cies can lead to large discrepancies between
measurements and model calculations, and their use
requires both caution and expert knowledge [47,62,63].
A data quality assessment can be used to evaluate whether
input data are suitable for the intended purpose. Such an
assessment involves "the scientific and statistical evalua-
tion of data to determine whether they meet the objectives
of the project, and thus are of the right type, quality, and
quantity to support their intended use" [64]. The Numer-
ical, Unit, Spread, Assessment and Pedigree (NUSAP) sys-
tem [27,65,66] is another method to assess data quality.
In addition to the more standard quantitative uncertainty
assessment (number, units and the spread of those num-
bers), the NUSAP approach also includes an evaluation of
the reliability of the information (assessment) and its the
scientific basis (pedigree).
Using the uncertainty typology in practice
In the preceding paragraphs we have outlined ways to deal
with various types of uncertainties. In practice, eBoD
assessments do not only have to deal with uncertainties,
but also with time and budget constraints. It might often
not be possible to employ all possible methods to deal
with all the uncertainties inherent in the assessment.
Therefore, it is necessary to prioritize uncertainties and the
work needed to assess or reduce them. Here we shortly
describe how to 1. identify and characterize sources of
uncertainty; 2. prioritize sources of uncertainties; and 3.
select and apply methods for dealing with uncertainties.
We will describe how, in all these steps, the uncertainty
typology can be used to support the process. Subsequent
communication of the results to policy makers will be dis-
cussed in the following paragraph.
1. First, the different sources of uncertainty are to be
identified. The generation of this longlist of uncer-
tainty sources can be done using two different
approaches: 1) by analyzing each step of the eBoD
assessment at hand and subsequently characterizing
each source according to the typology, and 2) by con-Environmental Health 2009, 8:21 http://www.ehjournal.net/content/8/1/21
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sidering each possible type from the uncertainty typol-
ogy and discussing where in the assessment this type
of uncertainty may occur. Reasoning from both angles
may help to minimize the chance that uncertainty
sources are overlooked. The resulting list of uncertain-
ties can be further characterized using the uncertainty
typology.
2. The relative importance of each uncertain element
can subsequently be weighted, based on its potential
impact on the outcome of the eBoD assessment in
question. Where some form of quantification is possi-
ble, the relative importance can be assessed by means
of sensitivity analysis [8-10]. However, for many
sources of uncertainty, such quantification is not fea-
sible. In that case, the relative importance can be
assessed using expert judgment. Two possible
approaches include coding and card sorting. In the
coding approach [67], experts are asked to go over the
longlist of uncertainty sources and code each source as
being either of a) a crucial importance; b) an average
importance; c) a medium importance or d) a low
importance. This is a quick and dirty technique and, to
avoid errors and biases, several experts should do this
independently and discuss potential differences in
their judgments. The card sorting approach (used by
e.g [68]) is more advanced and involves organizing an
expert workshop. Experts are asked to independently
select the top 20% (or another percentage) sources of
uncertainty that they consider most important in view
of their impact on the eBoD calculation at hand, and
sort these according to importance. The uncertainties
are displayed on cards to facilitate the sorting – hence
the name. Results from individual experts are com-
bined to arrive at a group ranking of the items on the
longlist. Arguments used by the experts to defend their
ranking need to be documented and special attention
should be given to reasons for any substantial disa-
greement on the importance of a particular uncer-
tainty source.
3. Once the prioritization has been done, suitable
tools can be selected for further analysis of the key
uncertainties identified. Each uncertainty type may
require a different method to address it, and to gauge
its impact on decision making. The uncertainty tool
catalogue by Van der Sluijs et al. [69] provides guid-
ance for selecting appropriate methods that match the
characterization of the uncertainty in the typology.
Refsgaard et al. [70] also describe various methods for
dealing with uncertainties, and explain which pur-
poses they may serve.
It may not be possible to correctly identify, characterize
and prioritize all sources of uncertainty in the beginning
of an assessment. The typology may thus need to be reas-
sessed throughout the project. New sources of uncertainty
may be added or their weights may be adjusted. The
uncertainty typology should therefore be used interac-
tively throughout the study. As such, it also provides a
framework to keep track of all sources of uncertainty, so
that sources identified early in the project – especially
those that cannot be quantified – are not forgotten at the
end of the study, when results are reported.
Communicating uncertain results to policy makers
Most policy makers will feel more comfortable when
making decisions based on single, undisputed numbers
with small uncertainty ranges, than on ambiguous or con-
troversial estimates and scenario analyses. However,
unfortunately that is often not the way complex processes
can be described. On the other hand, giving policy makers
a lengthy report listing all the possible uncertainties will
not necessarily lead to informed policy making either. Sci-
entists can help policy makers by assessing which uncer-
tainties are most relevant for the policy decisions to be
made. They can identify policy options that are robust
given these uncertainties. If no single best policy option
for all scenarios can be determined, all reasonable options
can be discussed in a democratic process including scien-
tists, stakeholders, policy makers and politicians [71]. As
the communication needs of all these parties can vary
greatly, a single mode of risk communication is rarely suf-
ficient.
Uncertainties can be communicated linguistically, numer-
ically, or graphically. Confidence intervals can be pro-
vided reflecting uncertainty in parameters and input data.
For uncertainties that cannot be expressed in statistical
intervals, other characterizations of likelihood can be
used. Risbey et al. [72] have proposed expressions for dif-
ferent levels of precision, ranging from full well defended
probability density functions, to percentile bounds, first
order estimates, expected signs or trends, ambiguous signs
or trends and, finally, effective ignorance. Many of the
uncertainties identified in our study cannot be captured
quantitatively, but some can be expressed in these latter
characterizations of precision. Additionally, if any policy
recommendations are made, the strength of these recom-
mendations and the quality of the underlying evidence
can be expressed using a uniform grading system [73,74].
Such a systematic and explicit approach to judging the
quality of evidence and the strength of recommendations
can facilitate appraisal of these judgments, and improve
communication [73,74]. Providing a graphical represen-
tation of the underlying model in a standardized way can
support further understanding of the assessment context
and model structure.Environmental Health 2009, 8:21 http://www.ehjournal.net/content/8/1/21
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In order not to overwhelm the user of the assessment
results with uncertainties, the concept of progressive dis-
closure of information can be employed [75,76]. This
involves tailoring the information about uncertainty to
the target audience. In a press release or a project sum-
mary, for example, the uncertainties that are most relevant
to the final policy decisions need to be described, without
any technical details. As such, a policy maker using the
results of an eBoD assessment will not be directly con-
fronted with a typology of all uncertainties, but will be
provided with the information needed to properly inter-
pret the results. The main assessment report may subse-
quently contain more detailed information, with
emphasis on the nature, extent and sources of uncertain-
ties. Ideally, it presents all methods, assumptions, param-
eters and input data, thereby providing maximum
transparency of the assessment approach. Even though
DALYs are made to reduce complex information to single
numbers, it is essential to allow readers to unravel the
DALYs and, when desired, reproduce them [11,57] or
recalculate any estimates using their own data or assump-
tions [77].
The assertion that burden of disease figures can only be
properly interpreted when presented with assessment-spe-
cific, informative and complete background information
leads to a second consideration related to the usability of
assessment results. They can only be used for the specific
purpose for which they were derived, and should not be
used in other assessments or for other policy purposes.
Discussion
Disability Adjusted Life Years – or other forms of aggre-
gated health measures – can be very attractive indicators
for policy makers. The measure combines information
about the magnitude, severity and duration of adverse
health effects into one number, thereby providing a
means to compare otherwise incomparable environmen-
tal health problems. This simplification of the complex
underlying reality is the defining advantage of the meas-
ure, but it also presents pitfalls. We have shown that vari-
ous types of uncertainty can influence environmental
burden of disease (eBoD) assessments and their output,
thereby potentially influencing policy decisions based on
these assessments. Statistically quantifiable uncertainty in
parameters and input data – the type of uncertainty that is
usually well communicated in eBoD assessments – is far
from the only type of uncertainty, or even the most impor-
tant. Variations in definitions of the environment, the
health effects, and the scenarios assessed, unknown
impacts of multi-causality and co-morbidity, lacking con-
sensus about causality, controversial views about model
structures, and many other sources of uncertainty may
affect eBoD assessments, but cannot be easily quantified,
and are usually not fully addressed.
The use of a typology to characterize and structure uncer-
tainties can help to deal with them. Dealing with uncer-
tainties does not necessarily mean reducing them. Much
of the time, mere identification and proper communica-
tion of uncertainties along with systematic reflection on
their policy implications is most important, or – more
practicably – the only feasible thing to do. Ideally, policies
should be robust under the uncertainties that are identi-
fied.
The potential extent of uncertainties presented here
should not be interpreted as criticism of the DALY
approach as such, or as an argument for not using the
method. Instead, for some assessments, DALYs can be a
very valuable way of presenting the possible extent of
environmental health effects to policy makers. Uncertain-
ties do not halt eBoD assessments, but do affect the assess-
ment process and the interpretation and communication
of its results. Scientists have the responsibility to assess
and communicate assessments in such a way that under-
lying uncertainties are reflected in the outcomes. Results
should not be presented as being more robust than can be
inferred from the underlying knowledge base. And policy
makers, for their part, have the responsibility to take infor-
mation about uncertainty seriously and deal with it sensi-
bly [78]. If not, then the interface between science and
policy needs to be re-designed, lest misdirected policies be
based on a false precision of scientific inputs.
In the meantime, on a meta-level, the methodology for
calculating the eBoD and dealing with uncertainties needs
to be improved [58]. For example, there should be a study
of the disproportionate way in which the uncertainty in
small severity weights (such as severe noise-related sleep
disruption [20,59]) affects overall assessment uncertainty.
The main limitation of the typology presented here is that
it strongly relies on expert judgment and mainly yields
qualitative insights. Its main application should be to pre-
cede and supplement quantitative uncertainty analysis,
and not to replace it. In addition, further research on sum-
mary measures can perhaps in the future lead to better
measures than DALYs, an area already explored by Murray
[58]. It is not possible to completely harmonize methods
and knowledge or to standardize datasets. These are often
highly assessment-specific, and should stay that way.
However, the criteria used for determining which meth-
ods and datasets to use should be harmonized as much as
possible. Overall, it would be useful to further study the
pitfalls of these types of aggregated indicators, and to
develop methods to identify and prevent the hyper-sensi-
tivity of policy decisions to overly precise indicators.Environmental Health 2009, 8:21 http://www.ehjournal.net/content/8/1/21
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Conclusion
Increased awareness of the issue of uncertainty and a well-
structured approach towards assessing and communicat-
ing uncertainties can help to bring about a more balanced
interpretation of the results of eBoD assessments. A typol-
ogy of uncertainties such as presented in this paper can be
used to systematically identify and map key uncertainties.
As such, it precedes and complements quantitative uncer-
tainty assessment. The use of a typology may facilitate a
structured dialogue between scientists and stakeholders
on possible sources and types of uncertainty. This may
help the key actors to achieve a common understanding of
the uncertainties and their importance.
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